Abiomed (ABMD) Reports In-Line Q3 EPS

February 6, 2013 7:20 AM EST Send to a Friend
Get Alerts ABMD Hot Sheet
Trade ABMD Now!
Join SI Premium – FREE
Abiomed, Inc. (NASDAQ: ABMD) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $38.3 million versus the consensus estimate of $38.04 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment